Factor Xa/thrombin inhibitors (Boehringer Ingelheim)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFactor Xa/thrombin inhibitors (Boehringer Ingelheim)
Drug Alias Nameanticoagulant (Boehringer)BIBT-853CLBIBR-830ZWBIBM-1015CL
ClassificationSmall molecules
Mechanisms of ActionFactor Xa inhibitorsFactor IIa inhibitorsPlatelet aggregation inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A